Linda Lembra

Editorial and Production Services

For all your medical editing and production needs...

Contact

Email: linda@lindalembra.co.uk

LinkedIn:  Linda Lembra

Full website to follow

Experience

• Over 25 years copyediting and proofreading
• Over 10 years production management: liaising with designers, typesetters, illustrators, printers and couriers
• 10 years project management – books and multimedia
• Managing projects to schedule and within budget from initiation to delivery of printed items
• Almost 15 years working within medical communications agencies
• Translations: liaison with translation agencies, managing translations and layout into foreign languages, line-checking translated materials
  

Skills

• PowerPoint – formatting and editing slides, including onsite at slide preview meetings before satellites and standalone meetings
• SMTP publishing – colour atlases, textbooks and multimedia projects
• Medical communications: primary and review articles; abstracts, oral presentations and posters; slide kits and training modules; product monographs; training manuals; patient materials; meeting materials (for symposia, ad boards, standalone meetings, speakers bureaux) including invitations, abstract books, signage, staging, banners and overnight newsletters; internal and external newsletters; HEOR reports
• Good knowledge and understanding of GPP and ABPI guidelines

Medical Communications Experience

Therapy areas: oncology (mainly RCC), ophthalmology (including AMD, DME), cardiovascular (including stroke prevention in atrial fibrillation, ACS, VTE prevention), anti-infectives (including MRSA), diabetology, neurology (Parkinson’s disease, Alzheimer’s), rheumatology (RA, OA), virology (including HIV, CMV, HCV), pharmacology, respiratory, women’s health, mental health (GAD, OCD)

Product experience: celecoxib (Celebrex, Searle), repaglinide (NovoNorm, Novo Nordisk), verteporfin (Visudyne, Novartis), vitravene (Fomivirsen, Novartis), ranibizumab (Lucentis, Novartis), rotigotine (Neupro, Schwarz Pharma), sorafenib (Nexavar, Bayer), rivaroxaban (Xarelto, Bayer), daptomycin (Cubicin, Novartis), efungumab (Mycograb, Novartis) Amikacin Inhale (Bayer), pazopanib (Votrient, GSK), everolimus (Afinitor, Novartis), levonorgestrel intrauterine system (Jaydess, Bayer), LBH589 (Panobinostat, Novartis), over-active bladder, irritable bowel syndrome